Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-150909
Filing Date
2020-05-26
Accepted
2020-05-26 08:28:33
Documents
3
Effectiveness Date
2020-05-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d916269ddefa14a.htm DEFA14A 29590
2 GRAPHIC g916269g81n53.jpg GRAPHIC 9717
3 GRAPHIC g916269sp147.jpg GRAPHIC 10838
  Complete submission text file 0001193125-20-150909.txt   59221
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-16174 | Film No.: 20908209
SIC: 2834 Pharmaceutical Preparations